Assessing the response of morphea and limited scleroderma to tranilast: a small prospective study comparing topical corticosteroids to a combination of topical corticosteroids and tranilast

Reference

• PetersonLSNelsonAMSuWPClassification of morphea (localized scleroderma)Mayo Clin Proc199570106810767475336
   PubMed Web of Science ®Google Scholar
• LeitenbergerJJCayceRLHaleyRWAdams-HuetBBergstresserPRJacobeHTDistinct autoimmune syndromes in morphea: a review of 245 adult and pediatric casesArch Dermatol2009145554555019451498
   PubMedGoogle Scholar
• FettNWerthVPUpdate on morphea: part I. Epidemiology, clinical presentation, and pathogenesisJ Am Acad Dermatol201164221722821238823
   PubMed Web of Science ®Google Scholar
• Sartori-ValinottiJCTollefsonMMReedAMUpdates on morphea: role of vascular injury and advances in treatmentAutoimmune Diseases2013 article ID 467808
   Google Scholar
• KrälingBMMaulGGJimenezSAMononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophagesPathobiology199563148567546275
   PubMed Web of Science ®Google Scholar
• JonesSPFrancoNFVarneyBExpression of the kynurenine pathway in human peripheral blood mononuclear cells: implications for inflammatory and neurodegenerative diseasePLoS one2015106e013138926114426
   PubMed Web of Science ®Google Scholar
• KurzinskiKTorokKSCytokine profiles in localized scleroderma and relationship to clinical featuresCytokine201155215716421536453
   PubMed Web of Science ®Google Scholar
• YangXYangJXingXWanLLiMIncreased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproductionArthritis Res Ther20141611
   Web of Science ®Google Scholar
• MunnDHZhouMAttwoodJTPrevention of allogeneic fetal rejection by tryptophan catabolismScience19982815380119111939712583
   PubMed Web of Science ®Google Scholar
• FallarinoFGrohmannUYouSTryptophan catabolism generates autoimmune-preventive regulatory T cellsTranspl Immunol2006171586017157218
   PubMed Web of Science ®Google Scholar
• LeeGKParkHJMacleodMChandlerPMunnDHMellorALTryptophan deprivation sensitizes activated T cells to apoptosis prior to cell divisionImmunology2002107445246012460190
   PubMed Web of Science ®Google Scholar
• PlattenMWickWVan den EyndeBJTryptophan catabolism in cancer: beyond IDO and tryptophan depletionCancer Res201272215435544023090118
   PubMed Web of Science ®Google Scholar
• WidnerBWernerERSchennachHWachterHFuchsDSimultaneous measurement of serum tryptophan and kynurenine by HPLCClin Chem19974312242424269439467
   PubMed Web of Science ®Google Scholar
• MartiLCPavonLSeverinoPSibovTGuilhenDMoreira-FilhoCAVascular endothelial growth factor-A enhances indoleamine 2, 3-dioxygenase expression by dendritic cells and subsequently impacts lymphocyte proliferationMem Inst Oswaldo Cruz20141091707924141959
   PubMed Web of Science ®Google Scholar
• Dziankowska-BartkowiakBZebrowskaAWagrowska-DanielewiczMKobosJWaszczykowskaESystemic sclerosis and scleroderma circumscripta–disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skinPrzegl Lek2008661210401045 Polish
   Google Scholar
• FallarinoFGrohmannUVaccaCT cell apoptosis by tryptophan catabolismCell Death Differ20029101069107712232795
   PubMed Web of Science ®Google Scholar
• MezrichJDFechnerJHZhangXJohnsonBPBurlinghamWJBrad-fieldCAAn interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cellsJ Immunol201018563190319820720200
   PubMed Web of Science ®Google Scholar
• DiNataleBCMurrayIASchroederJCKynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signalingToxicol Sci20101151899720106948
   PubMed Web of Science ®Google Scholar
• LoweMMMoldJEKanwarBIdentification of cinnabarinic acid as a novel endogenous Aryl hydrocarbon receptor ligand that drives IL-22 productionPLoS One201492e8787724498387
   PubMed Web of Science ®Google Scholar
• SkhirtladzeCDistlerODeesCSrc kinases in systemic sclerosis: central roles in fibroblast activation and in skin fibrosisArthritis Rheum20085851475148418438865
   PubMed Web of Science ®Google Scholar
• DentonCPAbrahamDJTransforming growth factor-β and connective tissue growth factor: key cytokines in scleroderma pathogenesisCurr Opin Rheumatol200113650551111698729
   PubMed Web of Science ®Google Scholar
• ArnettFCTanFKUzielYLaxerRMKrafchikBRAntohiSBonaCAutoantibodies to the extracellular matrix microfibrillar protein, fibrillin 1, in patients with localized sclerodermaArthritis Rheum199942122656265910616014
   PubMed Web of Science ®Google Scholar
• TanFKArnettFCAntohiSAutoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseasesJ Immunol199916321066107210395706
   PubMed Web of Science ®Google Scholar
• TomimuraSOgawaFIwataYAutoantibodies against matrix metalloproteinase-1 in patients with localized sclerodermaJ Dermatol Sci2008521475418565735
   PubMed Web of Science ®Google Scholar
• MihaiCTervaertJWAnti-endothelial cell antibodies in systemic sclerosisAnn Rheum Dis201069231932420107031
   PubMed Web of Science ®Google Scholar
• BelladonnaMLVolpiCBianchiRCutting edge: autocrine TGF-β sustains default tolerogenesis by IDO-competent dendritic cellsJ Immunol200818185194519818832670
   PubMed Web of Science ®Google Scholar
• SuzawaHKikuchiSAraiNKodaAThe mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblastsJpn J Pharmacol199260291961282576
   PubMedGoogle Scholar
• YamadaHTajimaSNishikawaTMuradSPinnellSRTranilast, a selective inhibitor of collagen synthesis in human skin fibroblastsJ Biochem199411648928977533764
   PubMed Web of Science ®Google Scholar
• NoakesRREffects of tranilast on the urinary excretion of kynurenic and quinolinic acid under conditions of L tryptophan loadingInt J Tryptophan Res201366771
   Google Scholar
• ChenYGuilleminGJKynurenine pathway metabolites in humans: disease and healthy states. International journal of tryptophan researchInt J Tryptophan Res2009211922084578
   PubMed Web of Science ®Google Scholar
• LovelaceMDVarneyBSundaramGCurrent evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosisFront Immunol2016724627540379
   PubMed Web of Science ®Google Scholar
• MurakamiTYoshiokaMYumotoRTopical delivery of keloid therapeutic drug, tranilast, by combined use of oleic acid and propylene glycol as a penetration enhancer: evaluation by skin microdialysis in ratsJ Pharm Pharmacol199850149549504434
   PubMed Web of Science ®Google Scholar
• KelseyCETorokKSThe localized scleroderma cutaneous assessment tool: responsiveness to change in a pediatric clinical populationJ Am Acad Dermatol201369221422023562760
   PubMed Web of Science ®Google Scholar
• FettNWerthVPUpdate on morphea: part II. Outcome measures and treatmentJ Am Acad Dermatol201164223124221238824
   PubMed Web of Science ®Google Scholar
• TaniguchiSYorifujiTHamadaTTreatment of linear localized scleroderma with the anti-allergic drug, tranilastClin Exp Dermatol19941953913937525127
   PubMed Web of Science ®Google Scholar
• NoakesRMellickNImmunohistochemical studies of the kynurenine pathway in morpheaInt J Tryptophan Res201369710224385714
   PubMedGoogle Scholar
• PetersonLSNelsonAMSuWPMasonTO’FallonWMGabrielSEThe epidemiology of morphea (localized scleroderma) in Olmsted County 1960–1993J Rheumatol199724173809002014
   PubMed Web of Science ®Google Scholar
• DarakhshanSPourABTranilast: a review of its therapeutic applicationsPharmacol Res201591152825447595
   PubMed Web of Science ®Google Scholar